Clinical Research Directory
Browse clinical research sites, groups, and studies.
To Evaluate the Safety and Efficacy of Pediococcus Acidilactici PA53 in Relieving Constipation in Adults
Sponsor: Wecare Probiotics Co., Ltd.
Summary
To study the improvement of constipation symptoms, quality of life and mental state, intestinal function, intestinal hormones, inflammation and immunity, and intestinal flora of constipation subjects after 8-week intervention with Pediococcus acidilactici PA53.
Official title: Pediococcus Acidilactici PA53 Supplementation Improves Stool Form and Modulates Gut Microbiota and Inflammatory Responses in Adults With Functional Constipation: A Randomized, Double-Blind, Placebo-Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
87
Start Date
2025-01-03
Completion Date
2025-06-06
Last Updated
2026-07-29
Healthy Volunteers
Yes
Conditions
Interventions
Probiotic
The experimental phase of this study had last 8 weeks and each patient will make 3 visits (week 0, week 4, week 8).
Maltodextrin
The experimental phase of this study had last 8 weeks and each patient will make 3 visits (week 0, week 4, week 8).
Locations (1)
Department of Nutrition, General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China